{"id":"https://openalex.org/W1966303173","doi":"https://doi.org/10.1016/0143-4179(84)90034-9","title":"Mu-receptor binding in physiological media: Comparison with isolated tissue data","display_name":"Mu-receptor binding in physiological media: Comparison with isolated tissue data","alternate_titles":[],"publication_year":1984,"publication_date":"1984-12-01","ids":{"openalex":"https://openalex.org/W1966303173","doi":"https://doi.org/10.1016/0143-4179(84)90034-9","mag":"1966303173","pmid":"https://pubmed.ncbi.nlm.nih.gov/6099521"},"language":"en","primary_location":{"id":"doi:10.1016/0143-4179(84)90034-9","doi":"https://doi.org/10.1016/0143-4179(84)90034-9","is_oa":false,"landing_page_url":"https://doi.org/10.1016/0143-4179(84)90034-9","pdf_url":null,"source":{"id":"https://openalex.org/S86238769","display_name":"Neuropeptides","issn_l":"0143-4179","issn":["0143-4179","1532-2785"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuropeptides","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1966303173"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"J.A Carroll","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J.A Carroll","raw_affiliation_strings":["Bioscience Department II, ICI Pharmaceuticals Division, Alderley Park, Macclesfield, Cheshire SK10 4TG, U.K"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bioscience Department II, ICI Pharmaceuticals Division, Alderley Park, Macclesfield, Cheshire SK10 4TG, U.K","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026414825","display_name":"Lynne Miller","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L Miller","raw_affiliation_strings":["Bioscience Department II, ICI Pharmaceuticals Division, Alderley Park, Macclesfield, Cheshire SK10 4TG, U.K"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bioscience Department II, ICI Pharmaceuticals Division, Alderley Park, Macclesfield, Cheshire SK10 4TG, U.K","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016969166","display_name":"John S. Shaw","orcid":"https://orcid.org/0000-0002-0296-4634","observed_orcids":["https://orcid.org/0000-0002-0296-4634"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J.S Shaw","raw_affiliation_strings":["Bioscience Department II, ICI Pharmaceuticals Division, Alderley Park, Macclesfield, Cheshire SK10 4TG, U.K"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bioscience Department II, ICI Pharmaceuticals Division, Alderley Park, Macclesfield, Cheshire SK10 4TG, U.K","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5108134727","display_name":"C. Peter Downes","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"C.P Downes","raw_affiliation_strings":["Bioscience Department II, ICI Pharmaceuticals Division, Alderley Park, Macclesfield, Cheshire SK10 4TG, U.K"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bioscience Department II, ICI Pharmaceuticals Division, Alderley Park, Macclesfield, Cheshire SK10 4TG, U.K","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5108134727"],"corresponding_institution_ids":[],"apc_list":{"value":3530,"currency":"USD","value_usd":3530},"apc_paid":null,"fwci":1.131,"has_fulltext":false,"cited_by_count":15,"citation_normalized_percentile":{"value":0.71907661,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"5","issue":"1-3","first_page":"89","last_page":"92"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10814","display_name":"Neuropeptides and Animal Physiology","score":0.9570000171661377,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10814","display_name":"Neuropeptides and Animal Physiology","score":0.9570000171661377,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.039799999445676804,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mu-opioid-receptor","display_name":"mu-opioid receptor","score":0.9800000190734863},{"id":"https://openalex.org/keywords/receptor-binding-affinity","display_name":"receptor binding affinity","score":0.8510000109672546},{"id":"https://openalex.org/keywords/opioid-antagonists","display_name":"opioid antagonists","score":0.5920000076293945},{"id":"https://openalex.org/keywords/partial-agonists","display_name":"partial agonists","score":0.9340000152587891},{"id":"https://openalex.org/keywords/enkephalin","display_name":"enkephalin","score":0.7540000081062317},{"id":"https://openalex.org/keywords/naloxone","display_name":"naloxone","score":0.8379999995231628},{"id":"https://openalex.org/keywords/isolated-tissue","display_name":"isolated tissue","score":0.4339999854564667},{"id":"https://openalex.org/keywords/brain-membranes","display_name":"brain membranes","score":0.574999988079071},{"id":"https://openalex.org/keywords/gtp-analogues","display_name":"GTP analogues","score":0.5120000243186951},{"id":"https://openalex.org/keywords/vas-deferens","display_name":"vas deferens","score":0.6679999828338623}],"concepts":[{"id":"https://openalex.org/C2780283098","wikidata":"https://www.wikidata.org/wiki/Q4688960","display_name":"Affinities","level":2,"score":0.8116762638092041},{"id":"https://openalex.org/C2778210472","wikidata":"https://www.wikidata.org/wiki/Q735505","display_name":"Vas deferens","level":2,"score":0.7555453777313232},{"id":"https://openalex.org/C2777803847","wikidata":"https://www.wikidata.org/wiki/Q325101","display_name":"Enkephalin","level":4,"score":0.6816059350967407},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.6556424498558044},{"id":"https://openalex.org/C41625074","wikidata":"https://www.wikidata.org/wiki/Q176088","display_name":"Membrane","level":2,"score":0.5636603832244873},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5601938962936401},{"id":"https://openalex.org/C2778815084","wikidata":"https://www.wikidata.org/wiki/Q79803","display_name":"Guinea pig","level":2,"score":0.5497461557388306},{"id":"https://openalex.org/C2778750930","wikidata":"https://www.wikidata.org/wiki/Q4540629","display_name":"(+)-Naloxone","level":4,"score":0.5183407068252563},{"id":"https://openalex.org/C2779886867","wikidata":"https://www.wikidata.org/wiki/Q421797","display_name":"Opioid receptor","level":4,"score":0.47268444299697876},{"id":"https://openalex.org/C3018795828","wikidata":"https://www.wikidata.org/wiki/Q899107","display_name":"Binding affinities","level":3,"score":0.436280757188797},{"id":"https://openalex.org/C12554922","wikidata":"https://www.wikidata.org/wiki/Q7100","display_name":"Biophysics","level":1,"score":0.3875006437301636},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.3193257451057434},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.2914237678050995},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.28967201709747314},{"id":"https://openalex.org/C2781063702","wikidata":"https://www.wikidata.org/wiki/Q427523","display_name":"Opioid","level":3,"score":0.26114118099212646},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.23433256149291992}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D004745","descriptor_name":"Enkephalins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006168","descriptor_name":"Guinea Pigs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009270","descriptor_name":"Naloxone","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D009294","descriptor_name":"Narcotics","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D011957","descriptor_name":"Receptors, Opioid","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D014649","descriptor_name":"Vas Deferens","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D017450","descriptor_name":"Receptors, Opioid, mu","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020875","descriptor_name":"Enkephalin, Ala(2)-MePhe(4)-Gly(5)-","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D066298","descriptor_name":"In Vitro Techniques","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/0143-4179(84)90034-9","doi":"https://doi.org/10.1016/0143-4179(84)90034-9","is_oa":false,"landing_page_url":"https://doi.org/10.1016/0143-4179(84)90034-9","pdf_url":null,"source":{"id":"https://openalex.org/S86238769","display_name":"Neuropeptides","issn_l":"0143-4179","issn":["0143-4179","1532-2785"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuropeptides","raw_type":"journal-article"},{"id":"pmid:6099521","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/6099521","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuropeptides","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.6240000128746033,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":5,"referenced_works":["https://openalex.org/W2075322499","https://openalex.org/W2092526105","https://openalex.org/W2094418127","https://openalex.org/W2269438443","https://openalex.org/W2342102423"],"related_works":["https://openalex.org/W2148947759","https://openalex.org/W1980104563","https://openalex.org/W4407023460","https://openalex.org/W1989721801","https://openalex.org/W2018974270","https://openalex.org/W2027711909","https://openalex.org/W2011470375","https://openalex.org/W2065703435"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1966303173","counts_by_year":[],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
